nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ACE—pulmonary artery—thymus cancer	0.0771	0.256	CbGeAlD
Cilazapril—ACE—vein—thymus cancer	0.0701	0.233	CbGeAlD
Cilazapril—Hepatitis cholestatic—Octreotide—thymus cancer	0.0419	0.06	CcSEcCtD
Cilazapril—Renal pain—Octreotide—thymus cancer	0.0321	0.046	CcSEcCtD
Cilazapril—Rectal haemorrhage—Octreotide—thymus cancer	0.0187	0.0268	CcSEcCtD
Cilazapril—Hyperkalaemia—Octreotide—thymus cancer	0.0166	0.0238	CcSEcCtD
Cilazapril—ACE—neck—thymus cancer	0.0159	0.0528	CbGeAlD
Cilazapril—Cramps of lower extremities—Octreotide—thymus cancer	0.0155	0.0222	CcSEcCtD
Cilazapril—Urine output increased—Octreotide—thymus cancer	0.0153	0.0219	CcSEcCtD
Cilazapril—SLC15A1—epithelium—thymus cancer	0.0151	0.0501	CbGeAlD
Cilazapril—Polyuria—Octreotide—thymus cancer	0.014	0.02	CcSEcCtD
Cilazapril—Cardiac failure congestive—Octreotide—thymus cancer	0.0135	0.0194	CcSEcCtD
Cilazapril—Hot flush—Octreotide—thymus cancer	0.0131	0.0188	CcSEcCtD
Cilazapril—Menopausal symptoms—Octreotide—thymus cancer	0.013	0.0186	CcSEcCtD
Cilazapril—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.0123	0.0176	CcSEcCtD
Cilazapril—ACE—hematopoietic system—thymus cancer	0.0119	0.0393	CbGeAlD
Cilazapril—ACE—epithelium—thymus cancer	0.0108	0.0359	CbGeAlD
Cilazapril—Bronchospasm—Octreotide—thymus cancer	0.0104	0.0149	CcSEcCtD
Cilazapril—Pancreatitis—Octreotide—thymus cancer	0.0104	0.0149	CcSEcCtD
Cilazapril—Sweating increased—Octreotide—thymus cancer	0.0103	0.0148	CcSEcCtD
Cilazapril—Bronchitis—Octreotide—thymus cancer	0.0102	0.0146	CcSEcCtD
Cilazapril—Dysuria—Octreotide—thymus cancer	0.00991	0.0142	CcSEcCtD
Cilazapril—Pollakiuria—Octreotide—thymus cancer	0.00979	0.014	CcSEcCtD
Cilazapril—Hyperglycaemia—Octreotide—thymus cancer	0.00956	0.0137	CcSEcCtD
Cilazapril—Conjunctivitis—Octreotide—thymus cancer	0.00918	0.0131	CcSEcCtD
Cilazapril—ACE—cardiac atrium—thymus cancer	0.009	0.0298	CbGeAlD
Cilazapril—Hepatobiliary disease—Octreotide—thymus cancer	0.00894	0.0128	CcSEcCtD
Cilazapril—Epistaxis—Octreotide—thymus cancer	0.00891	0.0128	CcSEcCtD
Cilazapril—Sinusitis—Octreotide—thymus cancer	0.00886	0.0127	CcSEcCtD
Cilazapril—ACE—pituitary gland—thymus cancer	0.00879	0.0291	CbGeAlD
Cilazapril—Bradycardia—Octreotide—thymus cancer	0.00863	0.0124	CcSEcCtD
Cilazapril—Rhinitis—Octreotide—thymus cancer	0.0085	0.0122	CcSEcCtD
Cilazapril—Hypoaesthesia—Octreotide—thymus cancer	0.00844	0.0121	CcSEcCtD
Cilazapril—Pharyngitis—Octreotide—thymus cancer	0.00842	0.0121	CcSEcCtD
Cilazapril—ACE—lymphoid tissue—thymus cancer	0.00834	0.0277	CbGeAlD
Cilazapril—Visual impairment—Octreotide—thymus cancer	0.00817	0.0117	CcSEcCtD
Cilazapril—Tinnitus—Octreotide—thymus cancer	0.00791	0.0113	CcSEcCtD
Cilazapril—Flushing—Octreotide—thymus cancer	0.00787	0.0113	CcSEcCtD
Cilazapril—Cardiac disorder—Octreotide—thymus cancer	0.00787	0.0113	CcSEcCtD
Cilazapril—SLC15A2—pituitary gland—thymus cancer	0.00767	0.0254	CbGeAlD
Cilazapril—Immune system disorder—Octreotide—thymus cancer	0.00766	0.011	CcSEcCtD
Cilazapril—ACE—bone marrow—thymus cancer	0.0076	0.0252	CbGeAlD
Cilazapril—ACE—thyroid gland—thymus cancer	0.00758	0.0251	CbGeAlD
Cilazapril—Arrhythmia—Octreotide—thymus cancer	0.00758	0.0108	CcSEcCtD
Cilazapril—Alopecia—Octreotide—thymus cancer	0.00749	0.0107	CcSEcCtD
Cilazapril—Flatulence—Octreotide—thymus cancer	0.00728	0.0104	CcSEcCtD
Cilazapril—Tension—Octreotide—thymus cancer	0.00724	0.0104	CcSEcCtD
Cilazapril—Nervousness—Octreotide—thymus cancer	0.00717	0.0103	CcSEcCtD
Cilazapril—Muscle spasms—Octreotide—thymus cancer	0.0071	0.0102	CcSEcCtD
Cilazapril—Tremor—Octreotide—thymus cancer	0.00692	0.0099	CcSEcCtD
Cilazapril—ACE—lung—thymus cancer	0.00688	0.0228	CbGeAlD
Cilazapril—Ill-defined disorder—Octreotide—thymus cancer	0.00685	0.00981	CcSEcCtD
Cilazapril—Anaemia—Octreotide—thymus cancer	0.00682	0.00977	CcSEcCtD
Cilazapril—Malaise—Octreotide—thymus cancer	0.00666	0.00953	CcSEcCtD
Cilazapril—Vertigo—Octreotide—thymus cancer	0.00663	0.0095	CcSEcCtD
Cilazapril—Syncope—Octreotide—thymus cancer	0.00662	0.00948	CcSEcCtD
Cilazapril—SLC15A2—thyroid gland—thymus cancer	0.00661	0.0219	CbGeAlD
Cilazapril—Palpitations—Octreotide—thymus cancer	0.00652	0.00934	CcSEcCtD
Cilazapril—Loss of consciousness—Octreotide—thymus cancer	0.00649	0.00929	CcSEcCtD
Cilazapril—Cough—Octreotide—thymus cancer	0.00644	0.00923	CcSEcCtD
Cilazapril—Hypertension—Octreotide—thymus cancer	0.00637	0.00913	CcSEcCtD
Cilazapril—Myalgia—Octreotide—thymus cancer	0.00629	0.009	CcSEcCtD
Cilazapril—Chest pain—Octreotide—thymus cancer	0.00629	0.009	CcSEcCtD
Cilazapril—Arthralgia—Octreotide—thymus cancer	0.00629	0.009	CcSEcCtD
Cilazapril—Anxiety—Octreotide—thymus cancer	0.00626	0.00897	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00624	0.00894	CcSEcCtD
Cilazapril—Discomfort—Octreotide—thymus cancer	0.00621	0.00889	CcSEcCtD
Cilazapril—Dry mouth—Octreotide—thymus cancer	0.00615	0.0088	CcSEcCtD
Cilazapril—Oedema—Octreotide—thymus cancer	0.00603	0.00863	CcSEcCtD
Cilazapril—SLC15A2—lung—thymus cancer	0.006	0.0199	CbGeAlD
Cilazapril—Shock—Octreotide—thymus cancer	0.00593	0.00849	CcSEcCtD
Cilazapril—Thrombocytopenia—Octreotide—thymus cancer	0.0059	0.00845	CcSEcCtD
Cilazapril—Tachycardia—Octreotide—thymus cancer	0.00588	0.00842	CcSEcCtD
Cilazapril—Skin disorder—Octreotide—thymus cancer	0.00585	0.00838	CcSEcCtD
Cilazapril—Hyperhidrosis—Octreotide—thymus cancer	0.00583	0.00834	CcSEcCtD
Cilazapril—Anorexia—Octreotide—thymus cancer	0.00574	0.00822	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00549	0.00786	CcSEcCtD
Cilazapril—Insomnia—Octreotide—thymus cancer	0.00545	0.0078	CcSEcCtD
Cilazapril—Paraesthesia—Octreotide—thymus cancer	0.00541	0.00775	CcSEcCtD
Cilazapril—Dyspnoea—Octreotide—thymus cancer	0.00537	0.00769	CcSEcCtD
Cilazapril—Somnolence—Octreotide—thymus cancer	0.00536	0.00767	CcSEcCtD
Cilazapril—Dyspepsia—Octreotide—thymus cancer	0.0053	0.00759	CcSEcCtD
Cilazapril—Decreased appetite—Octreotide—thymus cancer	0.00524	0.0075	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Octreotide—thymus cancer	0.0052	0.00745	CcSEcCtD
Cilazapril—Fatigue—Octreotide—thymus cancer	0.00519	0.00744	CcSEcCtD
Cilazapril—Pain—Octreotide—thymus cancer	0.00515	0.00738	CcSEcCtD
Cilazapril—Constipation—Octreotide—thymus cancer	0.00515	0.00738	CcSEcCtD
Cilazapril—Feeling abnormal—Octreotide—thymus cancer	0.00497	0.00711	CcSEcCtD
Cilazapril—Gastrointestinal pain—Octreotide—thymus cancer	0.00493	0.00706	CcSEcCtD
Cilazapril—Urticaria—Octreotide—thymus cancer	0.00479	0.00685	CcSEcCtD
Cilazapril—Abdominal pain—Octreotide—thymus cancer	0.00476	0.00682	CcSEcCtD
Cilazapril—ACE—lymph node—thymus cancer	0.00471	0.0156	CbGeAlD
Cilazapril—Hypersensitivity—Octreotide—thymus cancer	0.00444	0.00636	CcSEcCtD
Cilazapril—Asthenia—Octreotide—thymus cancer	0.00432	0.00619	CcSEcCtD
Cilazapril—Pruritus—Octreotide—thymus cancer	0.00426	0.0061	CcSEcCtD
Cilazapril—ABCB1—hematopoietic system—thymus cancer	0.00417	0.0138	CbGeAlD
Cilazapril—Diarrhoea—Octreotide—thymus cancer	0.00412	0.0059	CcSEcCtD
Cilazapril—SLC15A2—lymph node—thymus cancer	0.00411	0.0136	CbGeAlD
Cilazapril—Dizziness—Octreotide—thymus cancer	0.00398	0.00571	CcSEcCtD
Cilazapril—Vomiting—Octreotide—thymus cancer	0.00383	0.00549	CcSEcCtD
Cilazapril—ABCB1—epithelium—thymus cancer	0.00381	0.0126	CbGeAlD
Cilazapril—Rash—Octreotide—thymus cancer	0.0038	0.00544	CcSEcCtD
Cilazapril—Dermatitis—Octreotide—thymus cancer	0.0038	0.00544	CcSEcCtD
Cilazapril—Headache—Octreotide—thymus cancer	0.00377	0.00541	CcSEcCtD
Cilazapril—Nausea—Octreotide—thymus cancer	0.00358	0.00512	CcSEcCtD
Cilazapril—ABCB1—pituitary gland—thymus cancer	0.00309	0.0103	CbGeAlD
Cilazapril—ABCB1—lymphoid tissue—thymus cancer	0.00294	0.00974	CbGeAlD
Cilazapril—ABCB1—bone marrow—thymus cancer	0.00267	0.00887	CbGeAlD
Cilazapril—ABCB1—thyroid gland—thymus cancer	0.00267	0.00885	CbGeAlD
Cilazapril—ABCB1—lung—thymus cancer	0.00242	0.00803	CbGeAlD
Cilazapril—ABCB1—lymph node—thymus cancer	0.00166	0.00549	CbGeAlD
